![PDF) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria PDF) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria](https://www.researchgate.net/profile/Bhawna-Sirohi/publication/11845605/figure/tbl1/AS:667110120366096@1536062855708/Comparison-of-characteristics-in-patients-with-BJ-myeloma-IgG-and-IgA-myeloma-at_Q320.jpg)
PDF) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria
Article: Monoclonal gammopathy with significance: case series and literature review (full text) - Juli 2020 - NJM
![Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome | Cell Death & Disease Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-023-06037-y/MediaObjects/41419_2023_6037_Fig21_HTML.png)
Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome | Cell Death & Disease
![PDF) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria PDF) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria](https://i1.rgstatic.net/publication/11845605_Comparison_of_new_patients_with_Bence-Jones_IgG_and_IgA_myeloma_receiving_sequential_therapy_The_need_to_regard_these_immunologic_subtypes_as_separate_disease_entities_with_specific_prognostic_criteri/links/5433db6c0cf2bf1f1f264acb/largepreview.png)
PDF) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria
![PDF) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria PDF) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria](https://www.researchgate.net/profile/Bhawna-Sirohi/publication/11845605/figure/fig5/AS:271515555987480@1441745761646/Log-rank-comparison-of-overall-survival-of-patients-with-BJ-n-53-IgG-n-153-and_Q320.jpg)
PDF) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria
![PDF) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria PDF) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria](https://www.researchgate.net/profile/Bhawna-Sirohi/publication/11845605/figure/tbl2/AS:667110120386577@1536062855926/Comparison-of-treatment-received-and-response-to-treatment_Q320.jpg)
PDF) Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria
![PDF) Comparison of 24-hour versus random urine samples for determination and quantification of Bence Jones protein in a South African population PDF) Comparison of 24-hour versus random urine samples for determination and quantification of Bence Jones protein in a South African population](https://www.researchgate.net/publication/353712029/figure/tbl1/AS:1053440553791488@1628171208163/Comparison-of-the-advantages-and-disadvantages-of-random-and-24-h-urine-collection-for_Q320.jpg)